K2 PRINCIPAL FUND, L.P.

Position in TENX — Tenax Therapeutics, Inc.

CIK 1461790 TORONTO, A6

Position in TENX

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$145,500

New position

Shares Held

10,000

first reported quarter

Ownership

0.027%

of shares outstanding

% of Portfolio

0.04%

of 13F equity value

Holder Rank

#89

of 110 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

K2 PRINCIPAL FUND, L.P. holds $13,545,573 across 5 Biotechnology names. TENX ranks #5 (1.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	QURE	uniQure N.V.	78,601	$3,620,362
2	NKTR	Nektar Therapeutics	50,465	$3,522,961
3	ABVX	Abivax S.A.	24,403	$3,251,943
4	SPRY	ARS Pharmaceuticals, Inc.	375,132	$3,004,807
5	TENX	Tenax Therapeutics, Inc. This page	10,000	$145,500

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$145,500	10,000	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.